Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
MBX Biosciences, Inc. (MBX) had Return on Tangible Equity of -10.14% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-23.88M |
|
-- |
|
-- |
|
$26.53M |
|
$-26.53M |
|
$2.65M |
|
$-23.88M |
|
$-23.88M |
|
$-23.88M |
|
$-23.88M |
|
$-23.88M |
|
$-23.88M |
|
$-26.53M |
|
$-26.45M |
|
33.41M |
|
33.41M |
|
$-0.71 |
|
$-0.71 |
|
| Balance Sheet Financials | |
$244.28M |
|
$1.51M |
|
$1.65M |
|
$245.93M |
|
$10.48M |
|
-- |
|
$0.02M |
|
$10.50M |
|
$235.42M |
|
$235.42M |
|
$235.42M |
|
33.42M |
|
| Cash Flow Statement Financials | |
$-22.68M |
|
$3.23M |
|
$0.00M |
|
$49.35M |
|
$29.90M |
|
$-19.45M |
|
$1.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.14% |
|
|
Return on Tangible Equity |
-10.14% |
-9.71% |
|
-10.14% |
|
$7.04 |
|
$-0.68 |
|
$-0.68 |
|